Fuzapladib in a randomized controlled multicenter masked study in dogs with presumptive acute onset pancreatitis

Fuzapladib in a randomized controlled multicenter masked study in dogs with presumptive acute onset pancreatitis

Abstract Background Currently, no specific treatment is available for acute onset pancreatitis (AP), and management relies on symptomatic and supportive standard of care (SOC). Fuzapladib is a novel leukocyte function‐associated antigen type‐1 (LFA‐1) activation inhibitor, blocking activation and su...

Full description

Bibliographic Details
Main Authors: Joerg M. Steiner, Chantal Lainesse, Yuya Noshiro, Yumiko Domen, Heather Sedlacek, Stephen E. Bienhoff, Kelly P. Doucette, David L. Bledsoe, Hiroshi Shikama
Format: Article
Language:English
Published: Wiley 2023-11-01
Series:Journal of Veterinary Internal Medicine
Subjects:
canine acute onset pancreatitis
dog
fuzapladib
LFA‐1 activation inhibitor
lipase
Online Access:https://doi.org/10.1111/jvim.16897

Internet

https://doi.org/10.1111/jvim.16897

Similar Items